In observance of Lung Cancer Awareness Month this November, Metropolis Healthcare, one of India's leading and most reputed diagnostic chains, conducted a landmark seven-year research study (2015-2021) ...
CNSide Diagnostics will present data from the FORESEE trial showcasing the CNSide CSF Assay Platform’s utility in diagnosing and guiding ...
Medpage Today on MSN1d
Treatment of Oligometastatic EGFR-Mutant Lung CancerEGFR tyrosine kinase inhibitors (TKIs) are effective treatments for EGFR-mutant non-small cell lung cancer (NSCLC). However, ...
CURE® spoke with a lung cancer treatment expert about study findings showing survival benefits with the addition of ...
In September, amivantamab (Rybrevant; Johnson & Johnson) received its fourth treatment indication from the FDA to treat ...
Hosted on MSN2d
Lung cancer symptoms in people who've never smoked - and how it's different in smokersREAD MORE: Cancer-causing chemical detected in some acne treatments, says US laboratory Scientists at Yale Medicine have determined that genetic mutations or irregularities ... a subtype of non-small ...
The firms will initially develop a tool to identify NSCLC patients with EGFR mutations who can benefit from targeted therapy.
If approved by the EC, Tagrisso will be the first targeted therapy for European patients with unresectable EGFR-mutated cancer.
A new study presents a customised treatment strategy using antisense oligonucleotides (ASOs) to target EGFR mutations in ...
Blueprint Medicines' AYVAKIT leads its revenue growth, while its pipeline targets multiple cancers. Read why BPMC stock is a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback